Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer’s disease, positive for plasma p-tau217

202413 citationsJournal Articlegold Open Access

Authors

EudraCT 2015-000630-30 (primary) and NCT02579252.

Published in: Alzheimer s Research & Therapy

Volume 16, Issue 1, pp. 254-254

Field-Weighted Citation Impact: 4.37